G. Luporini

发表

A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care.

M. Maltoni, M. Pirovano, O. Nanni, 1999, Journal of pain and symptom management.

Cisplatin + 5-fluorouracil versus 5-fluorouracil alone in advanced colorectal cancer: a randomized study.

R. Labianca, G. Luporini, M. Clerici, 1988, European journal of cancer & clinical oncology.

Adjuvant Systemic Therapies in Patients with Colorectal Cancer: An Audit on Clinical Practice in Italy

S. Barni, R. Labianca, G. Luporini, 2005, Tumori.

A randomized clinical trial comparing radiation therapy v radiation therapy plus cis-dichlorodiammine platinum (II) in the treatment of locally advanced non-small cell lung cancer.

G. Luporini, M. Clerici, R. Zucali, 1988, Seminars in oncology.

Patterns of Care and Survival in Non Small Cell Lung Cancer: 15 Years’ Experience in a General Hospital

G. Luporini, V. Torri, M. Clerici, 1994, Tumori.

Cytogenetic Analysis in 28 Radically Operated Non-Small-Cell Lung Cancer: Preliminary Considerations

G. Luporini, M. Clerici, A. Lavezzi, 1989, Tumori.

Cardiac Toxicity of 5-Fluorouracil: A Study on 1083 Patients

R. Labianca, G. Luporini, M. Clerici, 1982, Tumori.

Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients

S. Barni, R. Labianca, G. Luporini, 1997, Supportive Care in Cancer.

A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum

G. Luporini, C. Gridelli, V. Lorusso, 1998 .

Medical Treatment of Colorectal Cancer in Elderly (>70 Years): Giscad Experience and Future Perspectives

S. Barni, R. Labianca, G. Luporini, 2002, Tumori.

A double-blind randomized study comparing intramuscular (i.m.) granisetron with i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin

M. Maltoni, D. Amadori, G. Luporini, 1999 .

A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder Cancer.

G. Luporini, C. Gridelli, V. Lorusso, 1998, European journal of cancer.

Cisplatin-associated anaemia in patients with solid tumours

R. Labianca, G. Luporini, M. Clerici, 1996, Supportive Care in Cancer.

Cisplatinum based chemotherapy: role of the antiserotoninergic ondansetron in prevention of emesis.

G. Luporini, A. D'Antona, M. Locatelli, 1993, Journal of chemotherapy.

Gemcitabine/cisplatin in advanced transitional cell carcinoma of the urinary tract (TCC): a phase II multicenter trial

G. Luporini, A. Santoro, V. Lorusso, 1999 .

Epirubucin, cisplatin, and continuous infusion 5‐fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An italian group for the study of digestive tract cancer (GISCAD) report

S. Barni, R. Labianca, G. Luporini, 1995 .

Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer.

S. Barni, R. Labianca, G. Luporini, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antitumor chemotherapy after fluorouracil angina

R. Labianca, G. Luporini, G. Beretta, 2004, Journal of Cancer Research and Clinical Oncology.

Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group.

G. Luporini, A. Rossi, C. Gridelli, 1999, Journal of the National Cancer Institute.

A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

S. Barni, R. Labianca, G. Luporini, 1999, British Journal of Cancer.

Efficacy and safety of levodropropizine and dihydrocodeine on nonproductive cough in primary and metastatic lung cancer.

S. Barni, G. Luporini, E. Marchi, 1998, The European respiratory journal.

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.

S. Barni, R. Labianca, G. Luporini, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Factors influencing response rates for advanced colorectal cancer chemotherapy.

R. Labianca, G. Luporini, G. Pancera, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Epirubicin treatment of advanced breast carcinoma with the weekly low-dose regimen.

R. Labianca, G. Luporini, G. Beretta, 1987, Oncology.

Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-α2b and folinic acid. The “GISCAD” experience

S. Barni, R. Labianca, G. Luporini, 1994 .

Biochemical Modulation of Fluoropyrimidines: the “Giscad” Studies

S. Barni, R. Labianca, G. Luporini, 1993 .

Subcutaneous administration of interleukin-2 and interferon-alpha 2b in advanced renal cell carcinoma: long-term results.

R. Labianca, G. Luporini, G. Beretta, 1999, Cancer detection and prevention.

Non small cell lung cancer treatment with vinorelbine monochemotherapy: a phase II study.

G. Luporini, M. Clerici, C. Casadio, 1995, Anticancer research.

5-fluorouracil cardiotoxicity: the risk of rechallenge.

R. Labianca, G. Luporini, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Medical treatment of hepatocellular carcinoma

R. Labianca, G. Luporini, G. Pancera, 1993, Journal of surgical oncology. Supplement.

Modulated 5-fluorouracil (5-FU) regimens in advanced colorectal cancer: a critical review of comparative studies.

M. Pirovano, R. Labianca, G. Luporini, 1996, European journal of cancer.

A cisplatinum-cyclophosphamide regimen in advanced ovarian cancer: reporting 5-year results.

R. Labianca, G. Luporini, M. Clerici, 1993, Oncology.

Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

S. Barni, R. Labianca, G. Luporini, 1998, British Journal of Cancer.

Salvage chemotherapy with paclitaxel in platinum-resistant advanced ovarian cancer patients.

G. Luporini, N. Ragni, E. Catsafados, 1996, Oncology.

Adjuvant Chemotherapy with Fluorouracil and ccnu in Colon Cancer. Results of a Multicentric Randomized Study

D. Amadori, G. Luporini, M. Marangolo, 1989, Tumori.

Multiple sebaceous tumors and carcinomas of the colon. Torre syndrome

G. Luporini, E. Alessi, L. Brambilla, 1985, Cancer.

High-versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a 'GISCAD' phase III study. Italian Group for the Study of Digestive Tract Cancer.

S. Barni, R. Labianca, G. Luporini, 1997, Annals of Oncology.

Mediterranean Kaposi's sarcoma in the elderly. A randomized study of oral etoposide versus vinblastine

R. Labianca, G. Luporini, S. Fossati, 1994, Cancer.

Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer).

S. Barni, R. Labianca, G. Luporini, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.